Trial Profile
A Double-blind, Randomized, Placebo-controlled, Double-dummy, Four-way Crossover Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2020
Price :
$35
*
At a glance
- Drugs Daridorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Idorsia Pharmaceuticals
- 18 Nov 2020 Results published in the CNS Drugs
- 12 Oct 2018 Status changed from recruiting to completed.
- 03 Oct 2018 Status changed from not yet recruiting to recruiting.